New shingles vaccine could reduce risk of dementia

Published on July 25, 2024

The new recombinant shingles vaccine ‘Shingrix’ is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study published in Nature Medicine. It is also more protective than vaccines against other infections.
Continue reading on website
Other news

Future of Oxford lactation research centre secured with £9.12 million donation

July 24, 2024
A £9.12 million gift from the Family Larsson-Rosenquist Foundation has endowed an Oxford University research centre investigating the role of hormones in human milk production.

Tech transfer partnership between universities creates company to transform care for millions of women

July 30, 2024
Amber Therapeutics (Tx), a start-up involving the University of Oxford, has just completed a $100 million Series A funding round from healthcare and technology investors in the US and UK to develop treatment for mixed urinary incontinence.